650 Page Mill Road, Palo Alto, CA
Earlens: Next Generation Hearing Technology Overview
Bill Facteau and Brent Edwards
CEO and CTO, Earlens Corporation
PLEASE NOTE: In order to cover the costs of dinner provided at our evening events, there is a nominal fee and registration is required. Walkins are welcome. For registration and information on cost, click here. Price listed above ($25) is the onsite registration fee. Discounts apply for early preregistration through the Bio2Device website.
The event starts at 6:00 pm with a light dinner and networking. The meeting starts at 6:45 pm with Harry Wachob (Bio2Device Founder) presenting the industry news for the week. The main presentation starts around 7:15 pm and is followed by questions. There is open networking and 1-on-1 questions until 9:00 pm. For more information about the event click here. To learn more about the Bio2Device Group visit our website.
Hearing technology is advancing rapidly. Hearables are the new wearables, with ear-level devices receiving considerable interest from tech developers for biometric measures, augmented audio, and hearing loss assistance. Earlens represents a transformative approach to hearing aids at a time when the hearing aid industry is in flux from convergence with consumer electronics in technology, markets, and regulations. By integrating directly with the eardrum and requiring a high level of care by both ENT physicians and audiologists, Earlens is innovating the technology, hearing performance, and distribution of a conservative industry ripe for change.
Bill Facteau is a medical device executive with 23 years of experience in the industry. He is currently the President & CEO at Earlens and serves on the Board of NeoTract. Previously he was the Vice Chairman of ExploraMed and an Entrepreneur in Residence at NEA. He was Chairman of the Board for Cabochon Aesthetics and a board member at CV Ingenuity prior to their acquisitions. Mr. Facteau was at Johnson & Johnson as WW President of their ENT Division. He joined JNJ via the $800M acquisition of Acclarent, where he served as the President & CEO. Under his leadership, the company went from concept to acquisition in 5 years, raised over $100M and grew revenues to $100M. Prior to Acclarent, Mr. Facteau was GM of the Endovascular Division at Abbott Vascular. He joined Abbott via the $683 million acquisition of Perclose, where he was Sales Director. From[masked], he worked at US Surgical. Mr. Facteau received his BA in Political Science from the Univ. of Connecticut.
Brent Edwards, Ph.D., is the CTO of Earlens and has spent 20 years as an executive in the hearing industry with a distinguished career in research and technology. He has made presentations at over 100 conferences, is an inventor on over 20 patents, and has published extensively in professional and trade publications on technology and market trends. Edwards founded the Starkey Hearing Research Center that is currently a leading site for research in hearing impairment, and his research into the effect of hearing technology on cognition created an international growth of research in this area. As VP of Research for Starkey Hearing Technologies, he led the development of many industry-changing technologies. Edwards is an elected Fellow of the Acoustical Society of America and his graduate work was a Ph.D. in Electrical Engineering followed by a postdoctoral fellowship in Psychology.
Refunds are not offered for this Meetup.